|
|
Volumn 22, Issue 7, 2014, Pages 1231-1232
|
|
Oncolytic viruses: Immune or cytolytic therapy?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ONCOLYTIC MEASLE VIRUS;
ONCOLYTIC VIRUS;
PEXASTIMOGENE DEVACIREPVEC;
TALIMOGENE LAHERPAREPVEC;
UNCLASSIFIED DRUG;
BRAIN CANCER;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
CELL ACTIVATION;
CLINICAL EFFECTIVENESS;
COLON CANCER;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG RESPONSE;
EDITORIAL;
GENE EXPRESSION;
GENETIC CODE;
GLIOBLASTOMA;
HUMAN;
IMMUNE RESPONSE;
IMMUNOCOMPETENT CELL;
MELANOMA;
METASTATIC MELANOMA;
MYELOMA;
OVERALL SURVIVAL;
TUMOR MICROENVIRONMENT;
GENETICS;
NEOPLASMS;
ONCOLYTIC VIROTHERAPY;
PHYSIOLOGY;
PROCEDURES;
HUMANS;
NEOPLASMS;
ONCOLYTIC VIROTHERAPY;
ONCOLYTIC VIRUSES;
|
|
EID: 84903725575
PISSN: 15250016
EISSN: 15250024
Source Type: Journal
DOI: 10.1038/mt.2014.94 Document Type: Editorial |
|
Times cited : (7)
|
|
References (0)
|
